methylprednisolone has been researched along with flunisolide in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (80.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Hausen, T | 1 |
Acquah, S; Dayrit, FM; Kohli, AR; Lee-Wong, M; Mayo, PH | 1 |
1 trial(s) available for methylprednisolone and flunisolide
Article | Year |
---|---|
Comparison of high-dose inhaled flunisolide to systemic corticosteroids in severe adult asthma.
Topics: Administration, Inhalation; Adolescent; Adrenal Cortex Hormones; Adult; Albuterol; Asthma; Confidence Intervals; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluocinolone Acetonide; Follow-Up Studies; Hospitals, Urban; Humans; Infusions, Intravenous; Male; Methylprednisolone; Middle Aged; Prednisone; Probability; Respiratory Function Tests; Severity of Illness Index; Statistics, Nonparametric; Treatment Outcome | 2002 |
4 other study(ies) available for methylprednisolone and flunisolide
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[Two out-of-the-ordinary (?) case reports an asthmatic disease].
Topics: Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Family Practice; Female; Fluocinolone Acetonide; Fluticasone; Humans; Male; Methylprednisolone; Middle Aged; Patient Compliance; Patient Education as Topic | 2000 |